The association between treatment and systemic inflammation in acromegaly.

Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
Thalijn L C WoltersR T Netea-Maier

Abstract

Acromegaly is characterized by an excess of growth hormone (GH) and insulin like growth-factor 1 (IGF1), and it is strongly associated with cardiovascular diseases (CVD). Both acute and long-lasting pro-inflammatory effects have been attributed to IGF1. Previous results suggest the presence of systemic inflammation in treated patients. Here we assessed the association between treatment of acromegaly, systemic inflammation and vascular function. Ex vivo cytokine production and circulating inflammatory markers were assessed in peripheral blood from treated and untreated acromegaly patients (N = 120), and compared them with healthy controls. A more comprehensive prospective inflammatory and vascular assessment was conducted in a subgroup of six treatment-naive patients with follow-up during treatment. Circulating concentrations of VCAM1, E-selectin and MMP2 were higher in patients with uncontrolled disease, whereas the concentrations of IL18 were lower. In stimulated whole blood, cytokine production was skewed towards a more pro-inflammatory profile in patients, especially those with untreated disease. Prospective vascular measurements in untreated patients showed improvement of endothelial function during treatment. Acromegaly pa...Continue Reading

References

Aug 21, 2002·Circulation·Jan FrystykHans Orskov
Jun 6, 2003·Lancet·Wiebke Arlt, Bruno Allolio
Jun 6, 2003·The Journal of Clinical Endocrinology and Metabolism·J C SmithJ S Davies
Oct 22, 2005·Infection and Immunity·Chantal A A van der GraafBart Jan Kullberg
Nov 23, 2006·Journal of Neuroimmunology·D LattuadaO Marelli
Jan 19, 2007·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Albert G BurgerAnne Klibanski
Aug 3, 2007·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Lucio VilarLuiz Augusto Casulari
Nov 1, 2007·The Journal of Clinical Endocrinology and Metabolism·O M DekkersJ P Vandenbroucke
Dec 19, 2007·Hypertension·Mark A BlackDaniel J Green
May 29, 2008·Endocrine Journal·Haruna SakaiYukio Hirata
Apr 23, 2010·The Journal of Clinical Endocrinology and Metabolism·A GiustinaUNKNOWN Acromegaly Consensus Group
Jan 27, 2012·Journal of Hypertension·Luc M Van BortelUNKNOWN European Network for Noninvasive Investigation of Large Arteries
Oct 30, 2012·Bioinformatics·Alexander DobinThomas R Gingeras
Mar 1, 2014·BioMed Research International·Oscar Mac AnaneyVincent Maher
Aug 26, 2014·Cardiovascular Ultrasound·Rosa Maria BrunoLorenzo Ghiadoni
Sep 28, 2014·Bioinformatics·Simon AndersWolfgang Huber
Oct 31, 2014·The Journal of Clinical Endocrinology and Metabolism·Laurence KatznelsonJohn A H Wass
Dec 18, 2014·Genome Biology·Michael I LoveSimon Anders
Feb 1, 2015·Matrix Biology : Journal of the International Society for Matrix Biology·Andrew C Newby
May 10, 2015·Pharmacology & Therapeutics·Uma RaiSimon A Young
Jun 15, 2017·Journal of Molecular Endocrinology·Thalijn Liliana Catharina WoltersRomana Teodora Netea-Maier
Aug 29, 2017·The New England Journal of Medicine·Paul M RidkerUNKNOWN CANTOS Trial Group
Jan 13, 2018·Cell·Siroon BekkeringMihai G Netea
Feb 9, 2019·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Yusuke HigashiSergiy Sukhanov
Apr 27, 2019·Annual Review of Immunology·Prakash Babu NarasimhanCatherine C Hedrick
Jun 19, 2019·European Heart Journal·Dick H J ThijssenLorenzo Ghiadoni
Nov 17, 2019·The New England Journal of Medicine·Jean-Claude TardifFrançois Roubille
Nov 22, 2019·Endocrine Connections·Thalijn Liliana Catharina WoltersRomana Netea-Maier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Related Papers

Endocrine Connections
Thalijn Liliana Catharina WoltersRomana T Netea-Maier
Reviews in Endocrine & Metabolic Disorders
Thalijn L C WoltersRomana T Netea-Maier
Semaine thérapeutique
R MORNEX, G SASSOLAS-FRANCHET
The Journal of Clinical Endocrinology and Metabolism
L M HURXTHAL, H F HARE
The Netherlands Journal of Medicine
S W LambertsJ C Birkenhäger
© 2021 Meta ULC. All rights reserved